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Abstract: The aim of this study was to evaluate the efficacies of Buparvaquone (an anti-theilerial drug) and Isometamidium 
chloride (a standard trypanocide) in the treatment of experimental Trypanosoma evansi infection in donkeys. Out of a total of 
24 donkeys, 6 were assigned to each of the experimental groups A1, A2, A3 and B at random. About 2.0x10
6
 T. evansi parasite 
in 2 mL inoculum was used to infect each of the donkeys in groups A1, A2 and A3 through jugular vein while group B remained 
as Un-infected control. On day 28 post-infection, animals in groups A2 and A3 were treated with Isometamidium chloride and 
Buparvaquone respectively. Parasitaemia levels were evaluated post-infection and post-treatment using Haematocrit 
Centrifugation Technique and supported with mice inoculation tests to ascertain effectiveness of treatments. Group means of 
parasitaemia were presented on graphs. Result showed that parasites were first detectable from peripheral blood of the infected 
animals from day 3 and by day 4 post-infection all animals were parasitaemic and the levels fluctuated in subsequent days. The 
infected-untreated group of animals was aparasitaemic on day 100 post-infection onward using haematocrit centrifugation 
technique test but mice inoculation test detected relapse with death of all mice used due to heavy parasitemia. Similarly, the 
buparvaquone-treated group was aparasitemic on day 49 post-treatment (corresponding to day 77 post-infection) but mice 
inoculation test detected relapse of parasitaemia in the group and all mice used also died. Isometamidium-treated animals were 
negative for parasitaemia for 50 days on mice inoculation test but later on day 100 post-treatment, showed 60% relapse with 
parasiaemia level of 1
+
 in the mice used and they did not die within 48 days of observation. In conclusion, experimental 
Trypanosoma evansi infection in donkeys have pre-patent period of 3-4 days, parasitaemia pattern is undulating and infected-
untreated animals became subclinical carriers from day 100 post-infection. The parasites in untreated, carrier animals 
maintained their virulence and pathogenicity. Buparvaquone on the other hand, depressed parasitaemia but the parasites were 
virulent and pathogenic to mice. Isometamidium chloride treatment resulted in incomplete clearance of parasitaemia due to 
Trypanosoma evansi and the relapsed parasites were avirulent and apathogenic. This is also the first report on the trial of 
buparvaquone for anti-Trypanosoma evansi effect in donkeys. 
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1. Introduction 
In Nigeria, donkeys (Equus africanus asinus) are 
widespread especially in the northern region, where they 
serve as source of traction power in transport and ploughing 
for both pastoralists and settled farmers [1]. Coincidentally, 
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T. evansi infection (surra) is endemic in donkeys in Nigeria 
[2]. The disease manifests as acute, in which case it is rapidly 
fatal in camels and horses or chronic form, which may persist 
for several months or years [3] as in donkeys which usually 
result in emaciation and death [4]. 
The causative agent; T. evansi belongs to the Salivaria 
section of pathogenic species of Trypanosoma and the 
subgenus, Trypanozoon which consists of three major 
trypanosome species; Trypanosoma brucei, T. evansi and T. 
equiperdum [5, 6]. 
The transmission of T. evansi among animals is 
mechanical, by biting flies mainly; Tabanus sp, and Stomoxys 
sp, Haematopota sp, Lyperosia sp and Chrysops sp [7]. 
Transplacental transmission mode has also been reported in 
donkeys [8]. 
The control of T. evansi infection in animals depends on 
chemotherapy and chemoprophylaxis relying on diminazene 
aceturate, quinapyramine, cymelarsan and suramin sodium, 
but emerging resistance of T. evansi strains to available drugs 
has limited the success of treatments [9, 10]. 
As part of efforts in the search for drugs with trypanocidal 
effects, the efficacies of buparvaquone and Isometamidium 
chloride against experimental T. evansi infection in donkeys 
were evaluated in this study. Buparvaquone is a second-
generation injectable hydroxynaphthoquinone compound in 
aqueous solution with both curative and prophylactic effects 
against the causative agents of Bovine Theileriosis; Theileria 
parva (T. parva), T. sergenti and T. annulata [11, 12]. 
Isometamidium chloride belongs to the same chemical group 
as homidium; the phenanthridine aromatic amidine 
compounds [13, 10]. 
2. Materials and Methods 
2.1. Location of Research 
The Experiment was conducted in the Department of 
Veterinary Parasitology and Entomology Research Pen, 
Faculty of Veterinary Medicine, Ahmadu Bello University, 
Samaru campus, Zaria, North-Western Nigeria. Main 
campus, Samaru, Zaria, North-Western Nigeria. Main 
campus in Samaru is located on latitude 11 ° 15’N to 11° 3’N 
of the equator and longitude 7° 30’E to 7° 45’E of Greenwich 
Meridian [14]. 
2.2. Experimental Animals 
Twenty four apparently healthy donkeys were purchased 
from International Livestock Market in Maigatari, Jigawa 
State, North-Western Nigeria and used for this experiment. 
The donkeys comprised of 12 males and 12 females, between 
the ages of 11 to 15 months old. The donkeys’ ages were 
estimated at point of purchase using dental eruption pattern 
of the incisors teeth as described by Wayne and Melvin [15] 
and Joe [16]. 
Four (4) apparently healthy and haemoparasites-free, adult 
albino Wistar rats, with body weight range of 200g-220g 
were used as donors for the propagation of T. evansi to obtain 
sufficient inoculum for the experimental infection. 
Mice inoculation tests (MIT) were conducted using 
apparently healthy and haemoparasites-free, adult Wistar 
mice (100 only) with body weight range of 14g-16g. Two 
mice were used for each donkey screened, each time, as 
support test for HCT at pre-infection phase to ensure that 
they were haemoparasites-free, post-infection and post-
treatment to determine relapse, ascertain effectiveness or 
otherwise of the treatment drugs against T. evansi infection. 
The rats and mice were sourced in batches from Animal 
Laboratory, Faculty of Pharmaceutical Sciences, Ahmadu 
Bello University, Zaria. 
2.3. Pre-infection Evaluation and Management of 
Experimental Animals 
2.3.1. Housing and Acclimatisation 
On arrival in the Department of Veterinary Parasitology 
and Entomology, A.B.U., Zaria, the experimental donkeys 
were further examined for signs of disease and external 
parasites infestations. Topical sweat-resistant fly-repellant 
spray (Endure
®
, Farnam co. inc., USA) was applied on the 
animals to keep flies away and then housed in prepared, fly-
proof experimental animal pen of the department. Wood 
shaving was used as bedding material on the floor of the pen; 
it was mucked daily to remove faecal droppings and changed 
as soon as the old one was bad. The experimental animals 
were acclimatised for 14 days [17]. 
In addition the following samples were collected and 
examined: 
2.3.2. Faecal Sample 
About 5g of fecal sample was collected from the rectum 
of each animal and examined for gastro-intestinal 
parasites using floatation and sedimentation methods as 
reported by Charles [18]. The animals were dewormed 
using Fenbendazole bolus (Fenacure
®
, Ashish Life 
Sciences PVT ltd, India) at the dose rate of 10mg/kg bd wt 
orally, once [19]. 
2.3.3. Blood Sample 
Four millilitres (4ml) of blood was collected from each 
animal through the jugular vein using 5ml syringe and 18G 
needle. Three milliliters of the blood was placed in blood 
sample bottle containing liquid tripotassium salt of Ethylene 
Diamine Tetra-acetate (EDTA+K3), 1mg/mL of whole blood 
as anticoagulant [20] and examined immediately for 
haemoparasites infections using 2 preparations of Wet Blood 
Film at 40x magnification, HCT and Giemsa Stained thin 
blood smear as reported by Weiser [21]. An average of 20 
microscope fields of the stained thin smear slide was 
examined. 
2.3.4. Animal Inoculation 
The balance of 1mL of blood collected from each donkey 
was transferred into sodium heparin-coated 1mL sterile 
disposable syringe with 29G X ½ inch needle and 0.5mL of 
the blood was injected into a mouse intra-peritoneally [17] 
using 2 representative mice per donkey [3]. The inoculated 
 Animal and Veterinary Sciences 2016; 4(3): 32-38 34 
 
mice were monitored for haemoparasites on HCT and Wet 
Film using tail tip blood at 48 hours intervals for 14 days 
[22], and remained under observation up to 60 days post-
inoculation. 
2.3.5. Feeding of Experimental Animals 
The experimental donkeys were provided with feed daily 
equivalent to 5% of their mean body weight, in the forms of; 
Sorghum/Maize stovers and Rhodes grass/groundnuts hay 
(4:1 ratio), the concentrate feed consisted of a mixture of 
sorghum grain (500g), dried groundnut cake (130g) and 
Maize/Wheat bran (2.5kg) per 200-300kg bd wt of animal. 
Salt lick blocks, rich in dicalcium phosphate and clean 
drinking water were provided ad-libitum as recommended by 
Aganga et al [23]. 
The albino rats and Wister mice were maintained in 
separate, labeled cages and were provided with commercially 
obtained pelletised feed in feeders and clean drinking water 
in sipper tubes ad libitum [17]. 
2.4. Identification and Grouping of Animals 
Serially numbered aluminum plates (about 5g) neck-tags 
were assigned to the donkeys at random for identification. A 
sample frame of each gender was prepared and treated one 
after the other by random picking of animals’ numbers and 
placing in experimental groups A1, A2, A3 and B to obtain a 
total of 6 animals (3 male and 3 female) in each experimental 
group. Choice of groups of animals inoculated with T. evansi 
as well as assigning of either Isometamidium chloride or 
Buparvaquone for group treatment was made at random [24]. 
The rats and mice were caged according to the group of 
donkeys they represented. Marks were applied on the various 
body parts of the rats and mice using permanent marker to 
reflect the donkey they represented. 
2.5. Propagation of Trypanosoma evansi 
Trypanosoma evansi (Sokoto isolate) originally isolated 
from camel and maintained in Wistar rats in the Department 
of Veterinary Parasitology and Entomology, Ahmadu Bello 
University, Zaria, was used in this experiment. 
The level of parasitemia of the infected Wistar rat was first 
determined to be +4 (representing greater than 20 parasites 
per field of microscope after examining 20 fields) on 
haematocrit centrifugation technique (HCT). One milliliter of 
parasitaemic blood was collected via ocular vein into 
heparinised sample bottle and diluted with 1mL phosphate 
buffered saline glucose solution. About 0.5 mL of the 
inoculums was inoculated into each of a set of 4 donor rats, 
intra-peritoneally using sterile 1mL disposable syringe, 25GX 
1
1
/2 inch needle [22, 17]. 
The donor rats were monitored for parasitaemia levels at 
48 hours intervals using Wet Film method. Twelve days 
post-inoculation, the 4 rats had attained between +2 to +4 
(i.e 6-10 to >20 parasites per microscope field). All donor 
rats were bled and the blood was pooled into a sterile 
conical flask containing heparin sodium 20 Units/mL of 
blood. A total of 15mL of pooled blood was obtained and 
the parasitemia was re-evaluated using haemocytometer 
[20]. The blood was diluted with phosphate buffered saline 
glucose solution to obtain an inoculum containing 1.0 x10
6
 
T. evansi /mL [22]. 
2.6. Experimental Infection and Monitoring of Animals 
The prepared inoculum was immediately used to infect the 
experimental animals in groups A1, A2 and A3 at the rate 
2mL (2.0x10
6
 T. evansi) per animal through the jugular vein 
and the day was considered as day0 of infection. Group B 
animals remained as Un-infected (control) group. 
The infected animals were monitored for parasitaemia 
using ear vein blood. The blood samples were collected once 
daily from all groups of animals between day1 and day7 
post-infection (PI). This was followed by blood collection 
twice per week between day8 and day 28 PI. The samples 
were examined using HCT and References and further 
reading may be available for this article. To view references 
and further reading you must purchase this article. Giemsa-
stained thin blood smears as reported by Elaine and Margi 
[20]. Levels of parasitemia were scored using the method of 
Woo [25]. 
2.7. Treatment of Specific Infected Animals 
On day 28 PI, which coincided with the third wave of 
parasitemia as determined on HCT, animals in groups A2 and 
A3 were treated and the day of first treatment was considered 
as day 0 of treatment. Group A1 was Infected but Untreated, 
A2 was Infected and treated with Isometamidium 
(Securidium
®
, Laprovet, France) 1% solution, 0.5mg/kg bd 
wt by deep intramuscular injection once [26] while group A3 
was infected and treated with Buparvaquone (Butalex
®
, 
Coopers K-brand Ltd, Kenya) 5% w/v, 2.5 mg/kg bd wt by 
deep intramuscular injection twice at 72 hours apart as 
recommended by the manufacturers. Animals in group B 
were uninfected and untreated (Control) 
2.7.1. Post-Treatment Monitoring 
The experimental donkeys were monitored further for 
levels of parasitemia for 148 days during which blood 
samples were collected from all animal groups as follows; 
once daily between day1 and day 7 post-treatment (PT), 
twice per week between day 8 and day 28 PT and once per 
week between day 29 and day 148 PT. The levels of 
parasitemia were evaluated on HCT and Giemsa-stained 
thin blood smear and were supported with mice inoculation 
test. 
2.7.2. Animal Inoculation 
Mice inoculation test (MIT) was performed for infected-
untreated in chronic stage of infection and for the infected, 
treated groups of donkeys post-treatment as a support for 
direct microscopic methods in-order to detect any case of 
subclinical infection. After 10 days or more of sustained 
aparasitemia from HCT in a group of donkeys, 1mL of blood 
was collected from each donkey in the group through jugular 
vein using heparin-coated 2mL syringe 19Gx 1
1
/2 inch needle. 
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Half millilitre (0.5mL) of collected blood was sub-inoculated 
into mouse intra-peritoneally using sterile 27G needles and 2 
representative mice per donkey. The mice were identified and 
monitored for parasitemia using tail blood on HCT and Wet 
Film at 48 hours intervals [3]. Based the observed 
aparasitaemic status by groups of animals, MIT was 
conducted as follows; 
Group A1 (Infected-Untreated) Donkeys: Blood samples 
were collected from the donkeys in the group on day 110 PI 
and sub-inoculated into mice. 
Group A2 (Infected, Isometamidium chloride-treated) 
Donkeys: Mice inoculation test was performed for the group 
on days 21, 50 and 100 PT. 
Group A3 (Infected, Buparvaquone-treated) Donkeys: 
Mice inoculation test was conducted for the group on day 
59 PT. 
3. Data Analysis 
Group means of parasitaemia levels in the various stages 
of the experiment were determined and graphs were prepared 
for post-infection and post-treatment phases of the 
experiment using Microsoft Excel 2010 [27]. 
4. Results 
The infection day 0, prepatent-period, undulating 
parasitaemia and treatment day 28 PI are as presented in Fig. 1. 
 
Fig. 1. Mean levels of parasitaemia in donkey experimentally infected with Trypanosoma evansi. 
 
Fig. 2. Mean levels of Trypanosoma evansi observed in experimentally infected donkeys post-treatment. 
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Group A1 (Infected-Untreated) 
The infected-untreated group of animals maintained an 
undulating wave of parasitaemia until it became 
aparasitaemic on HCT examination on day 100 PI, equivalent 
to day72 PT, (Fig. 2). Mice inoculation test (MIT) conducted 
on day 110 PI resulted in death of all mice, barely 15 days 
post-inoculation from heavy parasitemia (+3 and +4/field) on 
HCT and Wet Film (WF). 
Group A2 (Infected, Isometamidium chloride-treated) 
The T. evansi-infected, Isometamidium chloride-treated 
group of animals had sharp drop in mean parasitaemia on 
HCT from approximately 12/field on day1 to about 2/field on 
day 2 PT and they became aparasitaemic on day 11 PT (Fig. 
2). Mice inoculation tests on days 21 and 50 were negative 
but became positive on day 100 PT in 6/10(60%) of mice 
used representing 3/5(60%) donkeys in the group. The test 
(MIT) showed that there was no detectable parasitaemia 
within 50 days PT and that by day 100 PT, subclinical status 
is detectable in 3/5(60%) of the donkeys treated with 
isometamidium. The inoculated mice showed only 1 parasite 
(1+) per microscope field both on Wet Film and HCT during 
48 days of post-inoculation observation. The remaining 4 
mice were negative both on WF and HCT for the same 
period of observation (Fig. 2). 
Group A3 (Infected, Buparvaquone treated) 
The Infected, Buparvaquone treated group became 
aparasitaemic on HCT on day 49 PT (Fig. 2). Following MIT 
on day 59 PT, all inoculated mice tested positive for T. evansi 
and died by day 23 post-inoculation observation. 
5. Discussion 
In this study, a pre-patent period (PP) of 3-4 days was 
observed and could be due to the level of pathogenicity of 
Sokoto isolate of T. evansi or susceptibility of the animal as 
determined by immunotolerance of donkeys to T. evansi 
infection [28, 29]. 
The trend of parasitaemia in all groups of animals infected 
with T. evansi was undulating suggesting trypanosomes 
ability to reside intermittently in intra- or extra-vascular 
fluids [30] and switches of surface glycoprotein in antigenic 
variation causing relapses of parasitaemia and remittent 
clinical signs [31, 32, 33]. The parasitaemia detected from 
Infected-Untreated group of animals using MIT and the death 
of all mice as a result of high level of parasitaemia means 
that untreated donkeys became chronic subclinical carriers of 
low level, virulent and pathogenic parasites from day 100 PI 
but detectable on MIT [3]. The negative parasitaemia status 
(on MIT) exhibited by Isometamidium-treated group of 
animals for 50 days PT with the later show of relapse on day 
100 in 60% of treated animals which did not result in death 
of any of the inoculated mice suggest that Isometamidium 
chloride, controlled the T. evansi infection for 50 days as a 
standard trypanocides reported to have therapeutic and 
prophylactic effects against T. evansi infection for 2-4 
months in cattle [34, 35, 19], that relapse can occur in 60% of 
treated donkeys from day 100 PT onward and that treatment 
renders the T. evansi non-pathogenic and avirulent. This can 
be explained by the report that Isometamidium acts by 
cleavaging kDNA-topoisomerase complexes, resulting in the 
disintegration of minicircle network within T. evansi 
kinetoplast [36] and mechanisms apart from those dependent 
on kDNA [37]. The show of aparasitaemic status by 
buparvaquone-treated group earlier than the Infected-
Untreated group on HCT, with positive detection when MIT 
was used and death of all mice used for MIT from heavy 
parasitaemia suggest depression of parasitaemia due to 
buparvaquone treatment but the drug did not cure or clear 
infection and the donkeys were, therefore, chronic subclinical 
carriers of virulent and pathogenic T. evansi PI. 
6. Conclusion 
The dynamics of parasitemia in donkeys showed a pre-
patent period of 3 to 4 days and was charracterised by an 
undulating wave. The infected-untreated animals became 
chronic carriers with parasitaemia that was not detectable on 
HCT from day 100 PI onward but such parasites, when 
relapsed or detected using mice inoculation test, were 
virulent and pathogenic. 
Isometamidium chloride 1%, at 1mg/Kg body weight, 
intramuscularly dosed did not completely clear T. evansi 
infection in donkeys. Relapse of upto 60% in 
Isometamidium-treated animals was detected from day 100 
post-treatment using the mice inoculation test and the 
relapsed parasites were avirulent and non-pathogenic because 
they did not cause death of mice used for test. 
Buparvaquone, 5mg/kg body weight, intramuscularly 
dosed, twice at 3 days apart caused disappearance 
(depression) of parasitemia due to T. evansi infection from 
peripheral circulation in donkeys but do not cure infection. 
The parasites were detected using the mice inoculation test 
and such parasites were virulent and pathogenic because they 
caused death of all mice used for test despite exposure to 
buparvaquone treatment. This is the first report on the trial of 
buparvaquone for anti-trypanocidal effect. 
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